REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 4th, 2011 • Auxilio Inc • Services-business services, nec • California
Contract Type FiledAugust 4th, 2011 Company Industry JurisdictionTransactions with Management. In the table on the following page, describe any transaction (or series of similar transactions), during the Company’s last three Fiscal Years, or any currently proposed transaction (or series of similar transactions), to which the Company or any of its subsidiaries was or is to be a party, and in which you had or anyone in your immediate family has, a material direct or indirect financial interest. Identify the person(s) involved and state the nature of your or their interest in the transaction, the amount of the transaction and the amount of your or their interest in the transaction. (Attach a supplemental page if necessary.)
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 3rd, 2011 • Auxilio Inc • Services-business services, nec • California
Contract Type FiledAugust 3rd, 2011 Company Industry JurisdictionTransactions with Management. In the table on the following page, describe any transaction (or series of similar transactions), during the Company’s last three Fiscal Years, or any currently proposed transaction (or series of similar transactions), to which the Company or any of its subsidiaries was or is to be a party, and in which you had or anyone in your immediate family has, a material direct or indirect financial interest. Identify the person(s) involved and state the nature of your or their interest in the transaction, the amount of the transaction and the amount of your or their interest in the transaction. (Attach a supplemental page if necessary.)
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 16th, 2009 • Opexa Therapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledApril 16th, 2009 Company Industry JurisdictionThis Registration Rights Agreement (the “Agreement”) is made and entered into as of this 14th day of April, 2009, by and among Opexa Therapeutics, Inc., a Texas corporation (the “Company”), and the “Investors” named in that certain Unit Purchase Agreement by and among the Company and the Investors (the “Purchase Agreement”).